Amedisys Clinical Programs Team Achieves National Readmissions Prevention Collaborative (NRPC) Certification
18 August 2017 - 3:47AM
Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home
healthcare, hospice, and personal care companies, today announces
that their clinical programs team has completed the National
Readmission Prevention Collaborative (NRPC) certification program.
The certification program provides deeper training and examination
on how to appropriately address readmission issues in local
communities.
The certification was completed by the Amedisys clinical
programs team responsible for the development and delivery of
clinically distinct home healthcare programs, including Amedisys’
two newest programs aimed at chronic disease management for
Congestive Heart Failure and Chronic Obstructive Pulmonary Disease
(COPD) – two conditions responsible for the majority of hospital
readmissions. Amedisys is one of the first home care organizations
to receive this prestigious honor held in high regard by leading
acute hospitals that are being penalized if patients are readmitted
unnecessarily to the hospital.
“The Amedisys clinical programs team is proud to become
certified by NRPC. Our patients, wherever they may live, deserve
the best care possible to avoid unnecessary hospitalizations,” said
Amedisys Vice President of Clinical Programs and Innovation Shannon
Abbott.
“As an organization, we are committed to empowering our
patients, caregivers, clinicians and provider partners through
clinically-distinct programs focused on our most frail population
to improve outcomes and quality of life,” stated Amedisys Chief
Clinical Officer Susan Sender.
Amedisys’ commitment to clinical quality can be seen in its
Quality of Patient Care Star rating of 4.13, 3.25% above the
national average, as reported by the Centers for Medicare &
Medicaid Services (CMS).
“The NRPC certification is quite an accomplishment for the
Amedisys clinical team, as it requires extensive knowledge of the
healthcare sector as directed in the Affordable Care Act,” said
Josh Luke, Founder, and President of the National Readmission
Prevention Collaborative.
The certification process includes research, article reviews, a
project submission, and exam. More information on the certification
can be found at www.NationalReadmissionPrevention.com.
For more information on how Amedisys can help you or your loved
one, click here.
About Amedisys Amedisys, Inc. is a
leading healthcare at home Company delivering personalized home
health, hospice and personal care. Amedisys is focused on
delivering the care that is best for our patients, whether that is
home-based personal care; recovery and rehabilitation after an
operation or injury; care focused on empowering them to manage a
chronic disease; or hospice care at the end of life. More than
2,200 hospitals and 61,900 physicians nationwide have chosen
Amedisys as a partner in post-acute care. Founded in 1982,
headquartered in Baton Rouge, LA with an executive office in
Nashville, TN, Amedisys is a publicly held company. With
approximately 16,000 employees, in 421 care centers in 34 states,
Amedisys is dedicated to delivering the highest quality of care to
the doorsteps of more than 385,000 patients in need every year. For
more information about the Company, please
visit www.amedisys.com.
Contact:
Kendra Kimmons
Vice President of Marketing & Communications
225-299-3708
kendra.kimmons@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2024 to May 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From May 2023 to May 2024